Exact Mass: 408.1177424
Exact Mass Matches: 408.1177424
Found 108 metabolites which its exact mass value is equals to given mass value 408.1177424,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Methoxybenzenepropanol 1-(2-sulfoglucoside)
4-Methoxybenzenepropanol 1-(2-sulfoglucoside) is found in herbs and spices. 4-Methoxybenzenepropanol 1-(2-sulfoglucoside) is a constituent of fennel (Foeniculum vulgare) Constituent of fennel (Foeniculum vulgare). 4-Methoxybenzenepropanol 1-(2-sulfoglucoside) is found in herbs and spices.
2-Ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
Arteflene
C19H18F6O3 (408.11600699999997)
Omapatrilat
riboflavin thiamine
C17H20N4O6S (408.11035000000004)
Dehydroamorphigenin
Rhinacanthin D
A carboxylic ester obtained by the formal condensation of 2-hydroxy-3-(3-hydroxy-2,2-dimethylpropyl)naphthalene-1,4-dione with 1,3-benzodioxole-5-carboxylic acid. Isolated from Rhinacanthus nasutus, it exhibits antiviral activity.
Villosol
10,11-Dimethoxy-3,3-dimethyl-3H-pyrano[2,3:7,8][1]benzopyrano[3,2-b][1,5]benzodioxepin-7(14H)-one
Amorpholone
Dehydrotoxicarol
Isorobustin 4-methyl ether
3,6-Dimethoxy-6,6-dimethyl-3,4-methylenedioxypyrano[2,3:7,8]flavone
Ferrugone
Ichthynone
lindleyanin|rel-(1R,2R.2aS.9bR)-1,2,2a,9b-tetrahydro-9-metoxy-1-(7-methoxy-1,3-benzodioxol-5-yl)-2-methyl-3H-cyclobuta[c]furo[3,2-g][1]benzopyran-3-one
3,5,7,4,5-pentahydroxy-6-[1-(p-hydroxy-phenyl)ethyl]flavanone
3,3,10,10-Tetramethyl-5,8,13-trihydroxy-10H-dipyrano[3,2-a:2,3-i]xanthene-14(3H)-one
6a,12a-Didehydroamorphigenin
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.283 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.284 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.281
C18H20N2O9_2,4(1H,3H)-Pyrimidinedione, 1-[3-O-(4-hydroxy-2-methoxy-6-methylbenzoyl)-alpha-D-ribofuranosyl]
C18H20N2O9 (408.11687500000005)
C18H20N2O9_Uridine, 2-(4-hydroxy-2-methoxy-6-methylbenzoate)
C18H20N2O9 (408.11687500000005)
[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 4-hydroxy-2-methoxy-6-methylbenzoate
C18H20N2O9 (408.11687500000005)
[(2R,3R,4R,5R)-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] 4-hydroxy-2-methoxy-6-methylbenzoate
C18H20N2O9 (408.11687500000005)
[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 4-hydroxy-2-methoxy-6-methylbenzoate_major
C18H20N2O9 (408.11687500000005)
Cys Cys Pro Ser
Cys Cys Ser Pro
Cys Pro Cys Ser
Cys Pro Ser Cys
Cys Ser Cys Pro
Cys Ser Pro Cys
Pro Cys Cys Ser
Pro Cys Ser Cys
Pro Ser Cys Cys
Ser Cys Cys Pro
Ser Cys Pro Cys
Ser Pro Cys Cys
His-Met-OH
C17H20N4O6S (408.11035000000004)
4-Methoxybenzenepropanol 1-(2-sulfoglucoside)
ARTEFLENE
C19H18F6O3 (408.11600699999997)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
N,N-Dimethyl-2,7-diazapyrenium difluoroborate
C16H14B2F8N2 (408.12152799999996)
Methanone, (3,5-dimethyl-4-isoxazolyl)[4-[4-(methylsulfonyl)-2-nitrophenyl]-1-piperazinyl]-
C17H20N4O6S (408.11035000000004)
Zinc acexamate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2-(4-(1-(QUINOLIN-6-YLMETHYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRAZIN-6-YL)-1H-PYRAZOL-1-YL)ETHANOL HYDROCHLORIDE
omapatrilat
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
tesaglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
(S)-2-[(S)-(4-nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid isopropyl ester
2-(4-Methoxybenzyl)-2-[4-(4-methoxybenzyloxy)phenyl]acetic acid
N-[(2-chlorophenyl)methyl]-2-[7-oxo-3-(phenylmethyl)-6-triazolo[4,5-d]pyrimidinyl]acetamide
N-(4-chloro-2-methylphenyl)-3-[4-(2-methylpropylsulfamoyl)phenyl]propanamide
4-[(E)-2-[2,4-bis(trifluoromethyl)phenyl]ethenyl]-4,8-dimethyl-2,3-dioxabicyclo[3.3.1]nonan-7-one
C19H18F6O3 (408.11600699999997)
4-dimethoxyphosphoryl-2-(1-naphthalenyl)-N-(phenylmethyl)-5-oxazolamine
C22H21N2O4P (408.12388760000005)
6-(4,5-dihydrothiazol-2-ylthio)-N2,N4-bis(2-methylphenyl)-1,3,5-triazine-2,4-diamine
4-methoxy-N-[[1-[(3-methyl-2-thiophenyl)-oxomethyl]-3-piperidinyl]methyl]benzenesulfonamide
2-Amino-4-[5-methyl-2-(methylthio)-3-thiophenyl]-5-oxo-1-(3-pyridinyl)-4,6,7,8-tetrahydroquinoline-3-carbonitrile
4-phenyl-N-[6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-yl]-2-thiazolamine
2-(9-hydroxy-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl (E)-3-(4-hydroxyphenyl)prop-2-enoate
CCG-203971
CCG-203971 is a second-generation Rho/MRTF/SRF pathway inhibitor. CCG-203971 potently targets RhoA/C-activated SRE-luciferase (IC50 =6.4 μM). CCG-203971 inhibits PC-3 cell migration with an IC50 of 4.2 μM. Potential anti-metastasis Agent[1][2].
γ-Glu-Phe (TFA)
C16H19F3N2O7 (408.11442999999997)
γ-Glu-Phe TFA (γ-Glutamylphenylalanine TFA) is synthesized by Bacillus amyloliquefaciens (GBA) and Aspergillus oryzae (GAO). γ-Glu-Phe TFA or the post-enzymatic reaction mixture enhances the umami intensity of commercial soy sauce and model chicken broth[1].
(2r,3r,4r,5r)-4-hydroxy-2-(4-hydroxy-2-oxopyrimidin-1-yl)-5-(hydroxymethyl)oxolan-3-yl 4-hydroxy-2-methoxy-6-methylbenzoate
C18H20N2O9 (408.11687500000005)
6,7-dimethoxy-7',7'-dimethyl-2h-spiro[1-benzopyran-3,2'-furo[2,3-f]chromene]-3',4-dione
6-(3-hydroxyprop-1-en-2-yl)-16,17-dimethoxy-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),3,8,10,14,16,18-heptaen-12-one
9-formyl-6-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-(4-hydroxyphenyl)acetate
(1s,2r,4s,5r,14r,17r)-5-[(2s)-2-hydroxy-1-[(r)-methanesulfinyl]propan-2-yl]-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadeca-8,12-diene-7,15-dione
(1s,4as,5r,7r,7as)-5,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
5-(1,2-dihydroxyethyl)-4a-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-1-one
(1s,2r,5r,14s,17r)-5-[(2r)-2-hydroxy-1-[(s)-methanesulfinyl]propan-2-yl]-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadeca-8,12-diene-7,15-dione
(2r,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl 4-hydroxy-2-methoxy-6-methylbenzoate
C18H20N2O9 (408.11687500000005)
(1s,2r,4s,5r,10s,14s,17r)-5-[(2r)-2-hydroxy-1-methanesulfinylpropan-2-yl]-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadeca-8,12-diene-7,15-dione
(2s,14r,28r)-28-hydroxy-4,11,15,22-tetraazaheptacyclo[13.11.1.1²,¹⁴.0³,¹².0⁵,¹⁰.0¹⁶,²¹.0²³,²⁷]octacosa-1(27),3(12),4,7,9,16,18,20,22,24-decaene-6,26-dione
C24H16N4O3 (408.12223459999996)